Extracorporal life support for pulmonary hemorrhage in children: a case series

Nikoleta S Kolovos1, Douglas J E Schuerer, Frank W Moler

  • 1Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA. kolovos@umich.edu

Insights

Extracorporeal life support (ECMO) can be a life-saving therapy for children with severe respiratory failure due to pulmonary hemorrhage. This study shows all patients treated with ECMO survived and recovered fully.

Area of Science:

  • Pediatric critical care medicine
  • Cardiopulmonary support technologies
  • Respiratory failure management

Background:

  • Severe respiratory failure in children can be life-threatening.
  • Pulmonary hemorrhage presents a significant challenge in pediatric respiratory care.
  • Extracorporeal life support (ECMO) is a potential advanced therapy for refractory respiratory failure.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of ECMO in pediatric patients experiencing severe respiratory failure secondary to pulmonary hemorrhage.
  • To determine if pulmonary hemorrhage is a contraindication for ECMO therapy.
  • To assess the survival and recovery rates of children treated with ECMO for this condition.

Main Methods:

  • A retrospective case series design was employed.
  • Eight pediatric patients (<19 years) with severe respiratory failure and pulmonary hemorrhage were included.
  • Venoarterial or venovenous ECMO was utilized, with detailed monitoring of ventilatory parameters and oxygenation.

Main Results:

  • Pulmonary hemorrhage resolved within 24 hours in all patients.
  • All patients survived ECMO, decannulation, extubation, and hospital discharge.
  • Long-term follow-up (1-10 years) confirmed sustained survival.

Conclusions:

  • Extracorporeal life support is a viable and potentially life-sustaining treatment for pediatric severe respiratory failure with pulmonary hemorrhage.
  • Pulmonary hemorrhage should not be considered a contraindication for ECMO.
  • ECMO offers a critical supportive option for critically ill children with this condition.
Abstract